Latest Breaking News On - Zarnestra tipifarnib - Page 1 : comparemela.com

New York, USA, Nov. 21, 2023 (GLOBE NEWSWIRE) Peripheral T-Cell Lymphoma Market to Observe Growth at a CAGR of 4.9% in the US by 2032 | DelveInsight The rapid growth in the peripheral T-cell lymphoma market

United statesUnited kingdomNew yorkDaiichi sankyoAcrotech biopharmaShruti thakurZarnestra tipifarnibSecura bioBristol myers squibbDevices agencyGenor biopharma co ltdCitius pharmaceuticalsMerck sharp dohme corpMarket researchDizal pharmaceuticalsTeva pharmaceuticals